BANCR

ncRNA information

ncRNA name

BANCR

Specific or universal ncRNAs

Universal ncRNAs

Class

Long noncoding RNA

Biomarker

Yes

Biomarker application

Treatment

Upstream regulatory factors

Not available

Downstream target

miR-203/CSE1L

Cancer information

Cancer name

Colorectal Cancer

Cancer site

Colon, Rectum, and Anus

Treatment information

Treatment type

Chemotherapy

Drug

Adriamycin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

32

Male patients

19

Female patients

13

Age range and number

18(<=60)+14(>60)

Research information

PMID

Description

BANCR knockdown suppressed CRC progression and strengthened chemosensitization of CRC cells to ADR possibly by regulating miR-203/CSE1L.

Tissue resource

colorectal cancer tumor tissues and adjacent normal tissues

human colorectal cancer cell lines HCT116

None

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

Liaoning Cancer Hospital

China Center for Type Culture Collection

Country

China

Continent

Asia